{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:16:13Z","timestamp":1778656573378,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>\n                    Clear cell adenocarcinoma of the urinary tract (CCA-UT) is a rare, potentially aggressive tumor with very limited information regarding its clinicopathologic characteristics and molecular alterations. This study aimed to elucidate the clinicopathologic features and molecular landscape of one of the largest cohorts (35 cases) of this tumor, to identify genomic alterations and potential therapeutic targets. Seventy-nine percent of the patients were women, with a median age of 61 years. The urethra was the most common site (18; 51%), and all cases were \u2265pT2 (pT2:15; pT3:11; pT4:8). Twenty-nine percent of the patients died of their disease on follow-up. On whole-exome sequencing, pathogenic\/oncogenic alterations were identified in 91% (32\/35) cases. These alterations, most frequently involved chromatin modifiers (66% cases), including\n                    <jats:italic toggle=\"yes\">ATRX<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">KMT2C<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ARID1A<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">ARID1B<\/jats:italic>\n                    . Other frequently mutated genes included\n                    <jats:italic toggle=\"yes\">ATM<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">NF1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">ERBB2<\/jats:italic>\n                    . Ninety-seven percent (34\/35) of cases were microsatellite stable, and tumor mutational burden (TMB) was &gt;10 mut\/Mb in 9% (3\/35) of cases. Five cases were homologous recombinant-deficient on ScarHRD analysis, and 3 cases showed\n                    <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n                    mutations. Recurrent copy number loss events in Chr 1(p36.33-p35.3) were the most common copy number alterations (80%; n=28 cases). RNA-sequencing data analysis revealed numerous differentially expressed genes and enrichment of the epithelial-to-mesenchymal transition gene signature in individual samples. However, there was no statistical significance in the progression-free survival between cases with epithelial and mesenchymal phenotypes. CCA-UT are aggressive tumors with a heterogeneous molecular profile, underscoring the role of molecular analysis in identifying potential therapeutic options for the treatment of this pernicious tumor.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002527","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:00:30Z","timestamp":1772593230000},"page":"589-598","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1577-3586","authenticated-orcid":false,"given":"Manju","family":"Aron","sequence":"first","affiliation":[{"name":"Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshan S.","family":"Chandrashekar","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Alabama, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Adulfatah","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi P.","family":"Kunju","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel","family":"Zein-Sabatto","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Alabama, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Alabama, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Canete-Portillo","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Alabama, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni M.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Przybycin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaleel","family":"Al-Obaidy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University School of Medicine, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad T.","family":"Idrees","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University School of Medicine, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"Falzarano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela J.","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Alabama, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Netto","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Alabama, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"R2-20260513","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11255-019-02289-w","article-title":"The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma","volume":"52","author":"Patel","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"R3-20260513","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/jcm9010138","article-title":"Clear cell adenocarcinoma of the urinary bladder is a glycogen-rich tumor with poorer prognosis","volume":"9","author":"Zhou","year":"2020","journal-title":"J Clin Med"},{"key":"R4-20260513","first-page":"790235","article-title":"Clear cell adenocarcinoma of the urethra: review of the literature","volume":"2015","author":"Venyo","year":"2015","journal-title":"Int J Surg Oncol"},{"key":"R5-20260513","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-012-1363-3","article-title":"Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems","volume":"462","author":"Alexiev","year":"2013","journal-title":"Virchows Arch"},{"key":"R6-20260513","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R7-20260513","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"R8-20260513","doi-asserted-by":"crossref","first-page":"e00147","DOI":"10.1136\/jitc-2019-000147","article-title":"Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project","volume":"8","author":"Merino","year":"2020","journal-title":"J Immunother Cancer"},{"key":"R9-20260513","first-page":"PO.18.00400","article-title":"Cancer-specific thresholds adjust for whole-exome sequencing-based tumor mutational burden distribution","volume":"3","author":"Fernandez","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"R10-20260513","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13048-024-01565-3","article-title":"Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer","volume":"18","author":"Chiang","year":"2025","journal-title":"J Ovarian Res"},{"key":"R11-20260513","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2025.04.586","article-title":"Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumors","volume":"197","author":"Evans","year":"2025","journal-title":"Gynecologic Oncology"},{"key":"R12-20260513","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/bioinformatics\/btz632","article-title":"CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes","volume":"36","author":"daSilva","year":"2025","journal-title":"Bioinformatics"},{"key":"R13-20260513","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"R14-20260513","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R15-20260513","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","article-title":"Analyzing high-throughput sequencing data in Python with HTSeq. 2.0","volume":"38","author":"Putri","year":"2022","journal-title":"Bioinformatics"},{"key":"R16-20260513","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq","volume":"15","author":"Love","year":"2014","journal-title":"2 Genome Biol"},{"key":"R17-20260513","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R18-20260513","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s42003-023-04777-3","article-title":"Mapping the functional interactions at the tumor-immune checkpoint interface","volume":"6","author":"Bozorgui","year":"2023","journal-title":"Commun Biol"},{"key":"R19-20260513","doi-asserted-by":"crossref","first-page":"100821","DOI":"10.1016\/j.modpat.2025.100821","article-title":"Comprehensive molecular, pathological, and clinical characterization of clear cell adenocarcinoma of the urinary tract","volume":"38","author":"Rammal","year":"2025","journal-title":"Mod Pathol"},{"key":"R20-20260513","doi-asserted-by":"crossref","first-page":"105767","DOI":"10.1016\/j.humpath.2025.105767","article-title":"Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX17 in its differential diagnosis","volume":"157","author":"Zheng","year":"2025","journal-title":"Hum Pathol"},{"key":"R21-20260513","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4143\/crt.2023.577","article-title":"Clear cell adenocarcinoma of urethra: clinical and pathologic implications and characterization of molecular aberrations","volume":"56","author":"Song","year":"2024","journal-title":"Cancer Res Treat"},{"key":"R22-20260513","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43556-024-00175-1","article-title":"Chromatin modifiers in human disease: from functional roles to regulatory mechanisms","volume":"5","author":"Nie","year":"2024","journal-title":"Mol Biomed"},{"key":"R23-20260513","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","article-title":"The language of chromatin modification in human cancers","volume":"21","author":"Zhao","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R24-20260513","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/genes12060880","article-title":"Molecular characterization of M\u00fcllerian tumors of the urinary tract","volume":"12","author":"Ortiz-Br\u00fcchle","year":"2021","journal-title":"Genes (Basel)"},{"key":"R25-20260513","first-page":"101793","article-title":"Distinct mutational status in GATA3-positive clear cell adenocarcinoma of the urinary tract: A case report","volume":"39","author":"Abdelwahab","year":"2021","journal-title":"Urol Case Rep"},{"key":"R26-20260513","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ajpath.2013.11.023","article-title":"Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing","volume":"184","author":"Mehra","year":"2014","journal-title":"Am J Pathol"},{"key":"R27-20260513","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/1078-0432.CCR-24-1205","article-title":"Unveiling commonalities: exploring shared characteristics in clear-cell carcinomas of the gynecologic tract","volume":"30","author":"Blanc-Durand","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R28-20260513","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bjc.2017.228","article-title":"Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma","volume":"117","author":"Itamochi","year":"2017","journal-title":"Br J Cancer"},{"key":"R29-20260513","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"R30-20260513","doi-asserted-by":"crossref","DOI":"10.1111\/his.70096","article-title":"Molecular characterization of clear cell adenocarcinoma of the urinary bladder","author":"Jha","year":"2026","journal-title":"Histopathology"},{"key":"R31-20260513","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00428-019-02634-5","article-title":"Molecular profiling of clear cell adenocarcinoma of the urinary tract","volume":"475","author":"Lin","year":"2019","journal-title":"Virchows Arch"},{"key":"R32-20260513","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13000-023-01358-0","article-title":"A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations","volume":"18","author":"Struzinska","year":"2023","journal-title":"Diagn Pathol"},{"key":"R33-20260513","first-page":"309","article-title":"Somatic copy number alterations have prognostic impact in patients with ovarian clear cell carcinoma","volume":"40","author":"Morikawa","year":"2018","journal-title":"Oncol Rep"},{"key":"R34-20260513","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12885-023-11095-8","article-title":"Genomic landscapes of ovarian clear cell carcinoma from Latin countries reveal aberrations linked to survival and progression","volume":"23","author":"Batista","year":"2023","journal-title":"BMC Cancer"},{"key":"R35-20260513","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/healthcare10040694","article-title":"Ovarian endometrioid and clear cell carcinomas with low prevalence of microsatellite instability: a unique subset of ovarian carcinomas could benefit from combination therapy with immune checkpoint inhibitors and other anticancer agents","volume":"10","author":"Nonomura","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"R36-20260513","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ebiom.2019.11.017","article-title":"Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes","volume":"50","author":"Tan","year":"2019","journal-title":"EBioMedicine"},{"key":"R37-20260513","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers13081769","article-title":"Treatment strategies for ARID 1A-deficient ovarian clear cell carcinoma","volume":"13","author":"Takahashi","year":"2021","journal-title":"Cancers"},{"key":"R38-20260513","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.3390\/ijms232112815","article-title":"Targeting chromatin-remodeling factors in cancer cells: promising molecules in cancer therapy","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:00:20Z","timestamp":1778655620000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002527"}},"subtitle":["A Multi-Institutional Study"],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002527","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}